HARMONIZE was a phase @ , multicenter , randomized , double-blind , placebo-controlled trial evaluating zirconium cyclosilicate in outpatients with hyperkalemia ( serum potassium @ mEq/L ) recruited from @ sites in the United States , Australia , and South Africa ( March-August @ ) .